The many faces of nitric oxide in schizophrenia. A review.
about
Oxidative stress in schizophreniaA Review of Biomarkers in Mood and Psychotic Disorders: A Dissection of Clinical vs. Preclinical CorrelatesThe antipsychotic spiperone attenuates inflammatory response in cultured microglia via the reduction of proinflammatory cytokine expression and nitric oxide productionEvidence for the contribution of NOS1 gene polymorphism (rs3782206) to prefrontal function in schizophrenia patients and healthy controlsKidney-brain crosstalk in the acute and chronic setting.Modifications of blood platelet proteins of patients with schizophrenia.Effects of nitric oxide-related compounds in the acute ketamine animal model of schizophrenia.Behavioral, neurochemical and morphological changes induced by the overexpression of munc18-1a in brain of mice: relevance to schizophrenia.L-lysine as adjunctive treatment in patients with schizophrenia: a single-blinded, randomized, cross-over pilot study.Polyphenols from Berries of Aronia melanocarpa Reduce the Plasma Lipid Peroxidation Induced by Ziprasidone.Genetic analysis of nitric oxide synthase 1 variants in schizophrenia and bipolar disorder.Inter-relationship of plasma markers of oxidative stress and thyroid hormones in schizophrenics.Inhibitory effects of aripiprazole on interferon-gamma-induced microglial activation via intracellular Ca2+ regulation in vitro.Effects of the nitric oxide synthase inhibitor L-NAME on recognition and spatial memory deficits produced by different NMDA receptor antagonists in the rat.Pro-cognitive and antipsychotic efficacy of the alpha7 nicotinic partial agonist SSR180711 in pharmacological and neurodevelopmental latent inhibition models of schizophrenia.Role of nitric oxide and related molecules in schizophrenia pathogenesis: biochemical, genetic and clinical aspects.Schizophrenia shows a unique metabolomics signature in plasmaEffects of Atorvastatin on Negative Sign in Chronic Schizophrenia: a Double Blind Clinical Trial.S-nitrosylation of HDAC2 regulates the expression of the chromatin-remodeling factor Brm during radial neuron migration.Neurogenesis and schizophrenia: dividing neurons in a divided mind?Microvascular dysfunction in schizophrenia: a case-control study.A placebo-controlled study of sildenafil effects on cognition in schizophrenia.Microvascular abnormality in schizophrenia as shown by retinal imaging.Genes showing altered expression in the medial preoptic area in the highly social maternal phenotype are related to autism and other disorders with social deficitsComparative immunogenetics of autism and schizophrenia.Neuronal nitric oxide synthase (NOS1) and its adaptor, NOS1AP, as a genetic risk factors for psychiatric disorders.The nature, consequences, and management of neurological disorders in chronic kidney disease.Potential drug targets and treatment of schizophrenia.Fluorescence of 1,2-diaminoanthraquinone and its nitric oxide reaction product within macrophage cells.The Brain NO Levels and NOS Activities Ascended in the Early and Middle Stages and Descended in the Terminal Stage in Scrapie-Infected Animal Models.First description of enhanced expression of glia maturation factor-beta in experimantal toxoplasmic encephalitis.Role of oxidative stress in the pathophysiology of Toxoplasma gondii infection.Potential role of amino acids in pathogenesis of schizophrenia.Association between plasma nitric oxide metabolites levels and negative symptoms of schizophrenia: a pilot study.Increased cortical nitric oxide release after phencyclidine administration.Agmatine disrupts prepulse inhibition of acoustic startle reflex in rats.Inhibitory effects of polyphenol compounds on lipid peroxidation caused by antipsychotics (haloperidol and amisulpride) in human plasma in vitro.Elevated serum S100B protein in first-episode drug-naive Chinese patients with schizophrenia.Nitric oxide signaling in the medial prefrontal cortex is involved in the biochemical and behavioral effects of phencyclidine.Critical role of nitric oxide in the modulation of prepulse inhibition in Swiss mice.
P2860
Q24595660-5D0D06C1-D9F1-4C3D-9DCB-79FC0179FC5DQ26786354-73408EF9-AE92-4597-8FA5-3E2BFDC7368FQ28293593-39B678FF-F939-4223-918A-2A643D768404Q28649673-505941E4-8E52-4441-8E1C-45F1F5BFC45DQ30278845-F627A3DC-36BC-4040-8F96-CF8671993F10Q30375094-3504E240-056B-4F23-8C55-9DD360F2F915Q30416797-0F30F65C-A220-4178-9E8C-25B586B43CC5Q30458391-57A04282-E6A9-46EA-A901-A77E32CF954FQ30475497-A856270A-E4D5-43B3-A729-F949E5C59FCEQ33904833-7CACFF4D-590E-49C6-A1A6-FFB9745EC5A4Q34127018-5A20B2F8-1054-460B-B600-5F2A28AAC39AQ34215096-6416487B-4D90-4705-9AD7-19A952116578Q34590921-930145AB-BDCB-47FA-B739-DC54CF5612B2Q34660526-30CC6EEE-4B7B-4058-B7D8-74654E97C0D8Q34926526-9662F124-1B7A-4371-9D58-862CD85C40F7Q35591134-525E1203-7635-40CA-862B-20D41B9450C8Q36203421-5A308022-7D51-4CB3-9A38-E87F1EBCF142Q36358431-422B9DB2-95D1-484D-9953-544313EA6C4CQ36637329-F596E3A6-310E-42AA-990C-B2245B9935D9Q36806465-9B1AA066-BF31-4332-BC10-4764D1BD056DQ36848290-6A264CA0-84B3-4792-9117-2CF7AEF31909Q37247557-EC3204C3-710B-4CC5-833C-1CAC5C874655Q37379704-5D280C13-6376-449F-97C5-69EEE2778B86Q37531777-6D5EF375-F33A-4B93-889E-BE2D0507650FQ37886065-EDCA14A8-AE47-421E-A975-3E7C4B6EC787Q38328635-18C03AA5-3009-4184-96EC-3D1A83CFE0B7Q38629122-A5548722-EF52-429C-9E62-6B05A1719E4BQ39206300-D196E589-1F1F-4283-80B0-2C31BED2E3A2Q39467015-0AD88E31-7B84-4910-9D35-BD0D8AB35142Q39989946-C7B5909E-451E-4692-976E-8F7643E738C8Q40107932-75AECC4A-D37A-46A4-9606-95005D5FAB80Q40759669-658FD14D-A3CA-4437-87CD-35082D8B7695Q41706313-716A92DF-5D87-4FD9-9DBD-4077979A5341Q43145182-342C826F-34C3-4183-A183-B39E89563382Q45916154-B939C5B6-4734-4E9E-8DE7-D96737809AE8Q46090401-FF5686CF-B288-41FC-9A22-948AAE2BFE0BQ46117836-BE594C07-3A27-426A-8C72-18B888689904Q46156029-89999CC5-CCF4-47ED-89CA-CB28DFEC4B2CQ46981684-31BB1CAC-B044-4983-8747-AC7D63FB0084Q46986165-287056DE-DB9C-4FE5-A097-41B1BAE3A9C1
P2860
The many faces of nitric oxide in schizophrenia. A review.
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
The many faces of nitric oxide in schizophrenia. A review.
@ast
The many faces of nitric oxide in schizophrenia. A review.
@en
The many faces of nitric oxide in schizophrenia. A review.
@nl
type
label
The many faces of nitric oxide in schizophrenia. A review.
@ast
The many faces of nitric oxide in schizophrenia. A review.
@en
The many faces of nitric oxide in schizophrenia. A review.
@nl
prefLabel
The many faces of nitric oxide in schizophrenia. A review.
@ast
The many faces of nitric oxide in schizophrenia. A review.
@en
The many faces of nitric oxide in schizophrenia. A review.
@nl
P2093
P1476
The many faces of nitric oxide in schizophrenia. A review.
@en
P2093
Bernhard Bogerts
Gerburg Keilhoff
Hans-Gert Bernstein
P356
10.1016/J.SCHRES.2005.05.019
P407
P577
2005-10-01T00:00:00Z